Results 291 to 300 of about 1,254,762 (395)
Thrombosis as a Complication of Inflammatory Bowel Disease in Children
Khazal Paradis+2 more
openalex +1 more source
Gut metabolite trimethylamine N‐oxide accumulates in the diabetic wound area to amplify macrophage inflammation via enhancing glycolysis activities. Kinsenoside induces macrophage repolarization from M1 to M2 phenotype through inhibiting IRE1α/XBP1 pathway, followed by HIF‐1α‐glycolysis axis repression and mitophagy‐oxidative phosphorylation axis ...
Li Lu+13 more
wiley +1 more source
Cardiotonic Steroids as a Potential Novel Approach for Immunomodulation in Inflammatory Bowel Disease. [PDF]
Cavalcante-Silva LHA+5 more
europepmc +1 more source
Gasdermin D (GSDMD) does not only reduce pancreatic enzyme synthesis but also induces pancreatic acinar cells to express mucin 1 (MUC1), which forms a barrier to prevent digestive enzyme‐mediated digestion. However, GSDMD can promote the secretion of inflammatory cytokines by macrophages and aggravate pancreatic histological injury by expanding ...
Chaoxu Liu+10 more
wiley +1 more source
Obesity and Clinical Characteristics of Inflammatory Bowel Disease. [PDF]
Mancone R+6 more
europepmc +1 more source
Hepatotoxic Effect of Bile Acids in Inflammatory Bowel Disease
M. J. Dew+3 more
openalex +1 more source
Obese gut‐microbiota derived lipopolysaccharides (LPS) induce bone marrow macrophage senescence and GCA secretion via activating TLR4/NF‐κB/MAPKs pathway. Clinically, obese patients are associated with higher serum GCA levels. Mice with depletion of GCA gene show resistance to skeletal deterioration caused by obesity and LPS‐induced chronic ...
Min Huang+16 more
wiley +1 more source
Impact of Microbiota Diversity on Inflammatory Bowel Disease. [PDF]
Alzahrani AJ+5 more
europepmc +1 more source